Source link : https://newshealth.biz/health-news/who-benefits-most-from-immunotherapy-in-metastatic-crc/
TOPLINE: Compared with chemotherapy, immune checkpoint inhibitors (ICIs) were associated with improved overall survival in patients with microsatellite instable metastatic colorectal cancer (CRC), particularly when used as first-line therapy in routine clinical practice as well as in patients with high albumin levels and those who received antibiotics. Patients with microsatellite instable disease were also less […]
The post Who Benefits Most From Immunotherapy in Metastatic CRC? first appeared on News Health.
Author : News Health
Publish date : 2025-04-02 13:03:00
Copyright for syndicated content belongs to the linked Source.
in Health